{"id":"https://genegraph.clinicalgenome.org/r/d129de05-0d38-4938-a845-5c26ef08bbb3v1.0","type":"EvidenceStrengthAssertion","dc:description":"*HBA2* was first reported in relation to autosomal dominant erythrocytosis 7 in 1980 (Honig et al. 1980; PMID: 7213661). Erythrocytosis 7 is a disorder of the blood characterized by a high concentration of erythrocytes in the blood and an increased oxygen affinity of hemoglobin. Per criteria outlined by the ClinGen Lumping & Splitting Working Group, we found differences in molecular mechanisms, inheritance pattern, and phenotypic variability in erythrocytosis 7 relative to other disease entities associated with *HBA2*. Therefore, the following disease entities have been split into multiple curations: AD erythrocytosis, AD and AR alpha-thalassemia, unstable hemoglobin disease, and methemoglobinemia. This curation addresses only AD erythrocytosis. This curation includes at least 10 missense variants reported in 10 probands with AD erythrocytosis in 10 publications (PMIDs: 7213661, 1634363, 1634355, 11186265, 18818920, 19205974, 22959973, 25818820, 27240426, 33217156). This gene disease association is also supported by experimental evidence including expression, biochemical function, and protein-protein interactions (PMIDs: 11747442, 6644819). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen General Gene Curation Expert Panel on 10/25/2023 (SOP Version 9). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/d129de05-0d38-4938-a845-5c26ef08bbb3","GCISnapshot":"https://genegraph.clinicalgenome.org/r/6cd38d93-3dc1-429c-8f82-2269647f6bb5","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/6cd38d93-3dc1-429c-8f82-2269647f6bb5_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10026","date":"2023-10-25T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/6cd38d93-3dc1-429c-8f82-2269647f6bb5_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10026","date":"2024-06-28T18:49:27.127Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6cd38d93-3dc1-429c-8f82-2269647f6bb5_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6cd38d93-3dc1-429c-8f82-2269647f6bb5_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/998390a6-97b7-45c2-9c2a-b94045fec836","type":"EvidenceLine","dc:description":"The GCEP decided to upgrade this evidence in previous curations on the globin genes.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f02bf8f2-3fc0-4581-b571-fc1c8edb5f75","type":"Finding","dc:description":"The ability to bind and release oxygen is relevant to erythrocytosis, a disease characterized by an increased oxygen affinity of hemoglobin.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11747442","rdfs:label":"Kidd Biochemical Function","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9cd58d95-a485-4ff5-8168-488763ab1335","type":"EvidenceLine","dc:description":"The GCEP decided to upgrade this evidence in previous curations on the globin genes.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b9f6fbf3-7953-4f87-8131-09741a553784","type":"Finding","dc:description":"HBA1 protein physically interacts with the HBB gene product. This has been well-documented in the literature, and is shown here in a representative piece of evidence from an X-ray crystal structure of the hemoglobin complex in the oxygen-bound state. HBB encodes the beta-chain of hemoglobin and harbors missense variants associated with erythrocytosis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/6644819","rdfs:label":"Shaanan Protein-Protein","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/0ba05232-2cf7-4328-b603-e2b6cbf7d4ef","type":"EvidenceLine","dc:description":"The GCEP upgraded this evidence in previous curations on the globin genes","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e1655c9d-1c03-4f2c-82a9-ff16f68550d9","type":"Finding","dc:description":"Genotype-Tissue Expression (GTEx) shows that HBB is primarily expressed in whole blood, which is the tissue of interest for erythrocytosis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32913098","rdfs:label":"GTEx Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/6cd38d93-3dc1-429c-8f82-2269647f6bb5_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d4a7fe9-a594-4de2-9598-b85e215ae333","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d4a7fe9-a594-4de2-9598-b85e215ae333_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant showed increased oxygen affinity compared to HbA","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5d4a7fe9-a594-4de2-9598-b85e215ae333_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1634355","allele":{"id":"https://genegraph.clinicalgenome.org/r/1f81df39-e29c-4ff5-88dc-251891d085e1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000517.6(HBA2):c.122A>T (p.Lys41Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA214753"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/193f217e-b338-47e2-aa8b-fe1bb316a347","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/193f217e-b338-47e2-aa8b-fe1bb316a347_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant had a left-shifted oxygen dissociation curve","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/193f217e-b338-47e2-aa8b-fe1bb316a347_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11186265","allele":{"id":"https://genegraph.clinicalgenome.org/r/6b05553e-ba8e-4458-a4d7-9b1aaac7f0ff","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000517.6(HBA2):c.257A>T (p.Asp86Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125574"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7c4727d5-9d12-4ad2-8b57-653f86b5d572","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7c4727d5-9d12-4ad2-8b57-653f86b5d572_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25818820","allele":{"id":"https://genegraph.clinicalgenome.org/r/c4bc8291-4359-404c-a048-ac916270626b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000517.6(HBA2):c.142G>C (p.Asp48His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125569"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/e61926c5-ed17-4511-b282-22dd6db635a7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e61926c5-ed17-4511-b282-22dd6db635a7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant had increased oxygen affinity compared to WT HbA","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e61926c5-ed17-4511-b282-22dd6db635a7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22959973","allele":{"id":"https://genegraph.clinicalgenome.org/r/764b4825-72e1-4a63-bebb-21892ee155a5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000517.6(HBA2):c.382A>G (p.Lys128Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA276415458"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6273d231-0eed-4477-8127-ca7bce570752","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6273d231-0eed-4477-8127-ca7bce570752_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant had a left-shifted oxygen dissociation curve","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6273d231-0eed-4477-8127-ca7bce570752_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33217156","allele":{"id":"https://genegraph.clinicalgenome.org/r/9a8ef348-a3b9-4427-9824-28a24a8b06f2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000517.6(HBA2):c.422A>C (p.Tyr141Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA393994686"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7178c897-af41-4418-a8b3-18e481c52f82","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7178c897-af41-4418-a8b3-18e481c52f82_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Hemoglobin tonography revealed the variant had increased oxygen affinity","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/7178c897-af41-4418-a8b3-18e481c52f82_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19205974","allele":{"id":"https://genegraph.clinicalgenome.org/r/a70e2da3-a2da-4206-9307-2c432f2f316b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000517.6(HBA2):c.416C>T (p.Ser139Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA276415530"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/134c1e3f-eb8f-44a1-b119-e371b4accb99","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/134c1e3f-eb8f-44a1-b119-e371b4accb99_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18818920","allele":{"id":"https://genegraph.clinicalgenome.org/r/7e01362c-dc9b-4627-91bf-75c02f1d50cd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000517.6(HBA2):c.266C>T (p.Ala89Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125554"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/33d278bd-00b5-48f0-9130-8b89cd2e1d88","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33d278bd-00b5-48f0-9130-8b89cd2e1d88_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The P50 values of Hb Hanamaki were ~â…“ of those for HbA, indicating significantly increased oxygen affinity","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/33d278bd-00b5-48f0-9130-8b89cd2e1d88_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1634363","allele":{"id":"https://genegraph.clinicalgenome.org/r/09add430-c97c-4299-8538-c9d3586dd9e9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000517.6(HBA2):c.418A>G (p.Lys140Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125584"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e306014e-bc5c-4cb0-a07a-b0c8b6674963","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e306014e-bc5c-4cb0-a07a-b0c8b6674963_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27240426","allele":{"id":"https://genegraph.clinicalgenome.org/r/82bea100-d7d0-4624-abff-3eb304e1c53f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000517.6(HBA2):c.379G>A (p.Asp127Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125612"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/7cf706da-1003-4a29-b86d-baa0789f40a6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7cf706da-1003-4a29-b86d-baa0789f40a6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant had a left-shifted oxygen dissociation curve","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/7cf706da-1003-4a29-b86d-baa0789f40a6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7213661","allele":{"id":"https://genegraph.clinicalgenome.org/r/610ef710-b460-4e65-a60a-e88bc3fa17d7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000558.5(HBA1):c.134C>T (p.Pro45Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125827"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/31549dc0-c775-40b0-be7c-c74c4e957747","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31549dc0-c775-40b0-be7c-c74c4e957747_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25818820","allele":{"id":"https://genegraph.clinicalgenome.org/r/654ae282-b8c3-4172-bfcc-76fa2e9ea53c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000517.6(HBA2):c.116C>T (p.Thr39Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA276414577"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":3.9}],"evidenceStrength":"Limited","sequence":8551,"specifiedBy":"GeneValidityCriteria10","strengthScore":5.9,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ezgEkUNDx38","type":"GeneValidityProposition","disease":"obo:MONDO_0054802","gene":"hgnc:4824","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_6cd38d93-3dc1-429c-8f82-2269647f6bb5-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}